Moreover, it would be interesting to explore in more detail whether the therapeutic approach described in this manuscript is transferable to other hematologic neoplasms expressing the GFI1-36N variant (46). The gene discussed is GFI1; the disease is hematopoietic and lymphoid system neoplasm.